Cyclacel pharmaceuticals inc

Major-Pharmaceuticals

CYCC


200 Connell Drive
Berkeley Heights , NJ 07922

Executive/
Director

Price

  • Last Close
  • $ 0.24
    $ -0 -1.65 %
    Dec 15, 2023
  • 52-Week High/Low
  • $0.75 - $0.24
  • YTD
  • 0%

  • Trading Volume
  • 200,191
  • Market Cap Full
  • $ 3M
  • Shares Outstanding
  • 12.6M
    Nov 9, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 28.6% -23% -30.4% -22.4% 54.1% -5% -9% -21.6% -13.9% -
Q2 -11.1% 8.7% 2.5% -3.4% -40% 4% -16.7% -64.6% 1.6% -
Q3 -36.8% 19.5% -51.5% -2.8% -28.6% 8% -10.5% 35.2% -40.5% -
Q4 -1.2% -11.8% -7.9% -56.4% 72.5% 114% -26.6% -54.3% -32.3% -
J F M A M J J A S O N D
2024 - - - - - - - - - - - -
2023 37.9% -8.7% -31.7% 6.3% 4.9% -8.9% 14.8% -40.8% -12.4% 58.5% -45.5% -20.3%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    -83%-29%-12%-67%-65%13%1032%-50%-83%-64%0%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.19 0.19 0.38 -0.12 -0.14 -1.48 -0.5 -0.42 -7.05
Q2 0.10 1.01 0.50 -0.16 -0.11 -0.58 -0.56 -0.46 -6.60
Q3 0.08 0.86 0.91 -0.18 -0.11 -0.47 -0.54 -0.42 -7.20
Q4 0.10 0.69 - -0.16 -2.63 -0.89 -0.54 -9.00 -
A 0.5 2.8 1.8 -0.6 -3 -3.4 -2.1 -1.9 -20.85

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 17.2 17.2 7.1 10 12.5
Jun 12 17.2 4.9 9.2 10 12.5
Sep 12 17.2 4.9 9.2 12.5 12.6
Dec 12.5 17.2 4.9 10 12.5 12.6

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 4 5.8 3.7 5 3.3
Equity multiplier 0.2 0.1 - - -